Official Canadian Publication for Pharmaceutical & Biopharmaceutical Industry. Media Planner

Transcription

1 Official Canadian Publication for Pharmaceutical & Biopharmaceutical Industry Media Planner

2 Introduction Since Pharmaceutical Canada's introduction in June 2000, it rapidly evolved to a "must-have and must-read" trusted source of information for our colleagues in Pharmaceutical and Biopharmaceutical industries. All of us at Pharmaceutical Canada are committed to providing our subscribers with the most recent and truthful information available in order to assist the key decision makers having a better source of information when making purchasing assessment or acquiring services. Pricing pressures, weak product pipelines, patent expiries and safety concerns are just some of the challenges driving change in the pharmaceutical industry's traditional ways. By feedback from our subscribers, industry experts including our editorial advisory board, and trade organizations we constantly work hard to have better content to meet and surpass the needs of the ever changing marketplace. In other word each issue of Pharmaceutical Canada is filled with thought provoking coverage of what our subscribers need to know. Much of our success is due to industry experts who have kindly shared their time and knowledge. Circulation department continues to stay on top of ongoing company and personnel changes at subscriber organizations. We also maintain a high profile at leading industry trade shows and exhibitions. As you review our 2007 Media kit, you'll find out why the industry's most compelling read is also an effective Marketing tool for your company. I encourage you to contact us directly with any questions or suggestions you may have about our publication and how we can better meet your specific requirements.

3 To reach our subscribers Our efforts have made Pharmaceutical Canada the perfect choice for Pharmaceutical and Biopharmaceutical professionals. Pharmaceutical Canada has a circulation consisting of 10,000 mid-toupper level managers and professionals working on all phases of R&D, Method development, Quality, Production as well as Packaging and labelling. In addition to utilizing benchmark subscriber acquisition initiatives, we are also working to form several strategic relationships with associations, affinity groups, trade shows, and other applicable organizations to deliver Pharmaceutical Canada as an additional member benefit. Our focused content attracts and delivers top industry professionals and we continue our circulation endeavour to ensure that advertisers reach decision makers with purchasing influence. Business/Industry 1% 3% 3.5% 4.5% 6% Pharmaceutical, Biotech and allied Industries, Contract Laboratories: Manufacturing, Research, Process Development, Consultants, Independent Analytical Labs/Contract Research Academia - Universities, Research Institutes, Colleges 82% Architecture/Engineering/Construction/Validation Government (Health Canada, FDA, etc.) Industry Suppliers and Service Providers Business / Investment / Legal Services Job Function Tech/Analytical Service/Support 1%1.5% 3.5% Research & Development 39.5% 17% 12% 13% 12.5% Validation Quality Assurance Production and Manufacturing Marketing & Sales Mgmt Engineering Information Technology Position Held 5% Analysts 45% 21% 10.5% 18.5% Managers Director Associates Consultants

4 Editorial Focus Pharmaceutical Canada provides its readerships scientific, technical, management oriented non-biased "how to" articles with the goal to keep them informed about the latest developments in Pharmaceutical and Biopharmaceutical industries. Pharmaceutical Canada's news content covers a variety of events in the industry. Our 2007 editorial topics includes: Industry's key issues Laboratory Validation Life Sciences Biotechnology -Biosimilars Quality and Compliance Dissolution Manufacturing Technology CTD and ectd IT Stability Testing Packaging and labelling Transportation and Material Handling Outsourcing strategies Regulatory Affairs Excipients and Active Ingredients For guidelines on submitting articles and news releases, contact editor@pharmaceuticalcanada.ca

5 2007 Advertising Rates & Digital File Specifications 1x 2x 3x 4x $8600 $8300 $8000 $7800 $4900 $4650 $4450 $4150 $3700 $3500 $3400 $3100 $3700 $3500 $3400 $3100 $3100 $2850 $2650 $2450 $3100 $2850 $2650 $2450 $2700 $2550 $2350 $2100 $2700 $2550 $2350 $2100 $750 $700 $650 $600 $750 $700 $650 $600

6 Digital File Specifications A d s t o b e in e le c t r o n ic f o r m a t. S u p p ly C o lo r p r o o f s w it h a ll a d s Options for artwork are: - Quark Express 4.11 or earlier (Mac Format only) - Adobe Photoshop, CMYK (Mac/PC) - Adobe Illustrator, fonts to outlines (Mac/PC) - Hi-Res. EPS Files, CMYK (Mac/PC) - TIFF formats, CMYK and Min. 300 DPI (Mac/PC) * Please include fonts Full Page Ad Final magazine size 8.5"W x 11"H 8.5"W x 11"H 9.0"W x 11.50"H 8.0"W x 10.50"H Half Page Ad Final magazine size 4.25"W x 11"H (Vertical) Final magazine size 8.5"W x 5.5"H (Horizontal) 8.5"W x 5.5"H 9"W x 6"H 8"W x 5"H 1/3 Page Ad Final magazine size 8.5"W x 3.7"H (Horizontal) Final magazine size 2.8"W x 11"H (Vertical) 8.5"W x 3.7"H 9"W x 4.2"H 8"W x 3.2"H 1/4 Page Ad Final magazine size 4.25"W x 5.5"H 4.25"W x 5.5"H 4.75"W x 6"H 3.75"W x 5"H 4.25"W x 11"H 4.75"W x 11.5"H 3.75"W x 10.50"H 2.80"W x 11.00"H 3.30"W x 11.50"H 2.30"W x 10.50"H P le a s e s u b m it y o u r a r tw o r k a n d p r o o fs to : Attention: Rebecca Tan 200 Consumers Road, Suite 610 North York, Ontario Canada M2J 4R4 If y o u h a v e q u e s tio n s r e g a r d in g y o u r a r tw o r k p le a s e c a ll R e b e c c a T a n a t: Tel: Fax: rtan@pharmaceuticalcanada.ca

7 Sponsorship The one and only publication covering Canadian Pharmaceutical and Biopharmaceutical Industry from R&D to market, from molecules to products, from ideas to realities. Pharmaceutical Canada doesn't give readers "jargon". We give in-depth analysis of: Global and Canadian R&D developments and latest technologies and products available to the industry. Latest manufacturing and sourcing processes affecting productivity and quality aspect of pharmaceutical industry. Latest Global and Canadian regulatory changes and their effect on the industry. Changes of pharmaceutical landscape, emergence of new class of pharmaceuticals, deal makers, adn deal breakers. Canadian health care policies and its effect on the industry. It is a simple, effective and stimulating strategy to challenge the old way of thinking and foster the emergence of new thoughts. We have the pulse of the industry. 10 Good Reasons to Sponsor Connect with real decision makers in the industry; specialists, scientists, managers, and executives. Your support help in promoting and uniting of the pharmaceutical companies, academia, and suppliers together. Connect with the real users of your products and services. Powerful industry presence and branding. Quick, powerful business connections with colleagues and industry participants. Increase exposure and sales channels. Help create a stronger industry front. Support an important contribution to the knowledge based economy of Canada. Promote your products and services to the Canadian pharma and biopharma industry effectively. Inform industry professional and opinion leaders of your resources and opportunities.

8 Our Team Editorial Advisory Board PUBLISHER Dr. Mehrdad Barghian, President EDITOR IN CHIEF Dr. Yogesh Dandiker MARKETING & SALES Ray Taleghani, Director of Marketing & Business Development GRAPHIC DESIGN & ART WORK Rebecca Tan, Art Director Andy Lee, Graphic Designer CIRCULATION Robert Owen, Administration CHIEF ACCOUNTANT Cheung & Associate, Chartered Accountants The Editorial Advisory Board of Pharmaceutical Canada is a distinguished group of specialists representing various facet of Canadian Pharmaceutical Industry and Academia. Member of the board review manuscripts and suggest subject matter pertinent to the profession. All manuscripts must first be submitted to the Editor, Pharmaceutical Canada: editor@pharmaceuticalcanada.ca. Laleh Bighash, COO Academy of Applied Pharmaceutical Sciences Dr. Nicholas F. Cappuccino, Executive Vice President, Cheif Scientific Officer and Chief Technical Officer Andrx Pharmaceuticals Dr. Roshan Carpenter, Associate Director Regulatory Affairs GlaxoSmithKline Inc. Sultan Ghani, Acting Director, Bureau of Pharmaceutical Sciences TPD- Health Canada Dr. John C. Fanaras, President Nucro-Technics Dr. Salim Farah, Associate Director, Quality Assurance Apotex Dr. Helen Galat, Director of Manufacturing Improvements Sanofi Pasteur Dr. Pavel Hadina, MD, Professor of Pharmacology, Department of Cellular and Molecular Medicine University of Ottawa Dr. Syed Imtiaz Haider, Quality Affairs Director Julphar-Gulf Pharmaceutical Ind. George Markus, Consultant Dr. Mary Mazur-Melnyk, Consultant Innovalinks Dr. Manny Papadimitropoulos, Associate Director, Clinical Research, Operations Eli Lilly Canada Inc. Andrei Ponomarev, President AP-Pharma Compliance Associates (APPCA) Dr. Saeed A. Qureshi, D.Sc., Senior Research Scientist, Research Laboratory Bureau of Pharmaceutical Sciences TPD- Health Canada Dr. Arun V. Ravindran, MD, Professor of Psychiatry & Pharmacology, Scientific Director, Institute of Mental Health Research University of Ottawa Dr. Ravi Tan, R&D Manager Cobalt Pharmaceutical Inc. Ronald Turton, Chief Scientific Officer QCL Quality Compliance Laboratories David W. Vincent, CEO and COO Validation Technologies, Inc. Dr. Aaron Wolkoff, President Waters Canada